Onconova Therapeutics to Meet with Potential Investors and Business Development Partners at the Bio-Europe 24th Annual ...
NEWTOWN, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes ( …